U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C13H11N3O4S
Molecular Weight 305.309
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of BLI-489 FREE ACID

SMILES

[H][C@]12SC=C(N1C(=O)\C2=C\C3=CN4CCOCC4=N3)C(O)=O

InChI

InChIKey=DMEYZPJEFHGESJ-CPWLGJMPSA-N
InChI=1S/C13H11N3O4S/c17-11-8(12-16(11)9(6-21-12)13(18)19)3-7-4-15-1-2-20-5-10(15)14-7/h3-4,6,12H,1-2,5H2,(H,18,19)/b8-3-/t12-/m1/s1

HIDE SMILES / InChI
BLI 489 was developed by Wyeth as a 6-methylidene-penem β-lactamase inhibitor for the treatment of bacterial infections and urinary tract infections. BLI-489 has shown the promising clinical data, however, development of this drug, was discontinued.

Approval Year

PubMed

PubMed

TitleDatePubMed

Sample Use Guides

Unknown
Route of Administration: Intravenous
Name Type Language
BLI-489 FREE ACID
Common Name English
BLI 489 FREE ACID
Common Name English
4-THIA-1-AZABICYCLO(3.2.0)HEPT-2-ENE-2-CARBOXYLIC ACID, 6-((5,6-DIHYDRO-8H-IMIDAZO(2,1-C)(1,4)OXAZIN-2-YL)METHYLENE)-7-OXO-, (5R,6Z)-
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID60212945
Created by admin on Fri Dec 15 16:23:40 GMT 2023 , Edited by admin on Fri Dec 15 16:23:40 GMT 2023
PRIMARY
PUBCHEM
9972353
Created by admin on Fri Dec 15 16:23:40 GMT 2023 , Edited by admin on Fri Dec 15 16:23:40 GMT 2023
PRIMARY
CAS
635322-76-8
Created by admin on Fri Dec 15 16:23:40 GMT 2023 , Edited by admin on Fri Dec 15 16:23:40 GMT 2023
PRIMARY
FDA UNII
156B510BCG
Created by admin on Fri Dec 15 16:23:40 GMT 2023 , Edited by admin on Fri Dec 15 16:23:40 GMT 2023
PRIMARY